Advertisement
U.S. markets closed
Advertisement

CNS Pharmaceuticals, Inc. (CNSP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.1000-0.0300 (-1.41%)
At close: 04:00PM EST
2.0500 -0.05 (-2.38%)
After hours: 05:28PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close2.1300
Open2.1557
Bid2.0500 x 900
Ask2.1800 x 1000
Day's Range2.0000 - 2.2499
52 Week Range0.6110 - 4.4000
Volume37,364
Avg. Volume72,809
Market Cap11.022M
Beta (5Y Monthly)1.12
PE Ratio (TTM)N/A
EPS (TTM)-7.6000
Earnings DateNov 14, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CNSP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CNS Pharmaceuticals, Inc.
    Daily – Vickers Top Buyers & Sellers for 04/17/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    8 months agoArgus Research
View more